...
首页> 外文期刊>American Journal of Pathology: Official Publication of the American Association of Pathologists >The alternative and terminal pathways of complement mediate post-traumatic spinal cord inflammation and injury.
【24h】

The alternative and terminal pathways of complement mediate post-traumatic spinal cord inflammation and injury.

机译:补体的替代途径和终末途径介导创伤后脊髓炎症和损伤。

获取原文
获取原文并翻译 | 示例

摘要

Complement is implicated in the inflammatory response and the secondary neuronal damage that occurs after traumatic spinal cord injury (SCI). Complement can be activated by the classical, lectin, or alternative pathways, all of which share a common terminal pathway that culminates in formation of the cytolytic membrane attack complex (MAC). Here, we investigated the role of the alternative and terminal complement pathways in SCI. Mice deficient in the alternative pathway protein factor B (fB) were protected from traumatic SCI in terms of reduced tissue damage and demyelination, reduced inflammatory cell infiltrate, and improved functional recovery. In a clinically relevant paradigm, treatment of mice with an anti-fB mAb resulted in similarly improved outcomes. These improvements were associated with decreased C3 and fB deposition. On the other hand, deficiency of CD59, an inhibitor of the membrane attack complex, resulted in significantly increased injury and impaired functional recovery compared to wild-type mice. Increased injury in CD59-deficient mice was associated with increased MAC deposition, while levels of C3 and fB were unaffected. These data indicate key roles for the alternative and terminal complement pathways in the pathophysiology of SCI. Considering a previous study demonstrating an important role for the classical pathway in promoting SCI, it is likely that the alternative pathway plays a critical role in amplifying classical pathway initiated complement activation.
机译:补体与创伤性脊髓损伤(SCI)后发生的炎症反应和继发性神经元损害有关。补体可以通过经典途径,凝集素途径或其他途径激活,所有途径都共享一个共同的末端途径,最终形成细胞溶解膜攻击复合物(MAC)。在这里,我们调查了SCI中替代和末端补体途径的作用。从减少的组织损伤和脱髓鞘,减少的炎性细胞浸润和改善的功能恢复方面来说,在替代途径蛋白因子B(fB)缺乏的小鼠受到保护,免受创伤性SCI的伤害。在临床相关的范例中,用抗fB mAb治疗小鼠的结果相似。这些改善与减少的C3和fB沉积有关。另一方面,与野生型小鼠相比,缺乏CD59(膜攻击复合物的抑制剂)会导致损伤显着增加,并损害功能恢复。 CD59缺陷小鼠的损伤增加与MAC沉积增加有关,而C3和fB的水平不受影响。这些数据表明SCI的病理生理中替代和最终补体途径的关键作用。考虑到先前的研究表明经典途径在促进SCI中起重要作用,因此替代途径可能在放大经典途径引发的补体激活中起关键作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号